Home | Welcome to Contract Pharma   
Last Updated Wednesday, July 23 2014
Print

Breaking News

May 7, 2014
Andreasson brings extensive biopharma ops experience   Read More »
May 7, 2014
Adds early phase development and CMC services  Read More »
May 7, 2014
Smith to develop scientific excellence and enhance R&D platforms  Read More »
May 7, 2014
Specialty pharma sales up 10% in the quarter  Read More »
May 6, 2014
Sommerville to support U.S. regulatory activities for epilepsy programs  Read More »
May 6, 2014
Evotec will employ its drug discovery platform to identify a clinical candidate  Read More »
May 6, 2014
Providers need to develop integrated marketing plans   Read More »
May 6, 2014
Decline in royalties impacts results  Read More »
May 6, 2014
Cytovance to manufacture SELK2 drug product  Read More »
May 6, 2014
CMC to manufacture oncology product candidate  Read More »
May 6, 2014
Bayer to acquire OTC business for $14.2 billion  Read More »
May 5, 2014
Revenue down 9% in the quarter  Read More »
May 5, 2014
Zeiher and Barrett to head Global Development and Medical Affairs  Read More »
May 5, 2014
BGB-283 BRAF inhibitor achieves clinical milestone  Read More »
May 5, 2014
Aims to develop gene therapy products for ophthalmologic diseases  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On